Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis

A pilot study

Geetha Mohan, Sergey Magnitsky, Gerd Melkus, Karupppasamy Subburaj, Galateia Kazakia, Andrew J. Burghardt, Alexis Dang, Nancy E Lane, Sharmila Majumdar

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Osteoarthritis (OA) is a major degenerative joint disease characterized by progressive loss of articular cartilage, synovitis, subchondral bone changes, and osteophyte formation. Currently there is no treatment for OA except temporary pain relief and end-stage joint replacement surgery. We performed a pilot study to determine the effect of kartogenin (KGN, a small molecule) on both cartilage and subchondral bone in a rat model of OA using multimodal imaging techniques. OA was induced in rats (OA and KGN treatment group) by anterior cruciate ligament transection (ACLT) surgery in the right knee joint. Sham surgery was performed on the right knee joint of control group rats. KGN group rats received weekly intra-articular injection of 125 μM KGN 1 week after surgery until week 12. All rats underwent in vivo magnetic resonance imaging (MRI) at 3, 6, and 12 weeks after surgery. Quantitative MR relaxation measures (T and T2) were determined to evaluate changes in articular cartilage. Cartilage and bone turnover markers (COMP and CTX-I) were determined at baseline, 3, 6, and 12 weeks. Animals were sacrificed at week 12 and the knee joints were removed for micro-computed tomography (micro-CT) and histology. KGN treatment significantly lowered the T and T2 relaxation times indicating decreased cartilage degradation. KGN treatment significantly decreased COMP and CTX-I levels indicating decreased cartilage and bone turnover rate. KGN treatment also prevented subchondral bone changes in the ACLT rat model of OA. Thus, kartogenin is a potential drug to prevent joint deterioration in post-traumatic OA.

Original languageEnglish (US)
Pages (from-to)1780-1789
Number of pages10
JournalJournal of Orthopaedic Research
Volume34
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Osteoarthritis
Rodentia
Joints
Cartilage
Knee Joint
Bone Remodeling
Anterior Cruciate Ligament
Articular Cartilage
Therapeutics
Bone and Bones
Replacement Arthroplasties
Multimodal Imaging
Osteophyte
Intra-Articular Injections
Synovitis
kartogenin
Histology
Tomography
Magnetic Resonance Imaging
Pain

Keywords

  • 7T MRI
  • cartilage
  • kartogenin
  • Osteoarthritis
  • subchondral bone

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Mohan, G., Magnitsky, S., Melkus, G., Subburaj, K., Kazakia, G., Burghardt, A. J., ... Majumdar, S. (2016). Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis: A pilot study. Journal of Orthopaedic Research, 34(10), 1780-1789. https://doi.org/10.1002/jor.23197

Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis : A pilot study. / Mohan, Geetha; Magnitsky, Sergey; Melkus, Gerd; Subburaj, Karupppasamy; Kazakia, Galateia; Burghardt, Andrew J.; Dang, Alexis; Lane, Nancy E; Majumdar, Sharmila.

In: Journal of Orthopaedic Research, Vol. 34, No. 10, 01.10.2016, p. 1780-1789.

Research output: Contribution to journalArticle

Mohan, G, Magnitsky, S, Melkus, G, Subburaj, K, Kazakia, G, Burghardt, AJ, Dang, A, Lane, NE & Majumdar, S 2016, 'Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis: A pilot study', Journal of Orthopaedic Research, vol. 34, no. 10, pp. 1780-1789. https://doi.org/10.1002/jor.23197
Mohan, Geetha ; Magnitsky, Sergey ; Melkus, Gerd ; Subburaj, Karupppasamy ; Kazakia, Galateia ; Burghardt, Andrew J. ; Dang, Alexis ; Lane, Nancy E ; Majumdar, Sharmila. / Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis : A pilot study. In: Journal of Orthopaedic Research. 2016 ; Vol. 34, No. 10. pp. 1780-1789.
@article{880baf2f1fb84f25afef74ac0ed842a4,
title = "Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis: A pilot study",
abstract = "Osteoarthritis (OA) is a major degenerative joint disease characterized by progressive loss of articular cartilage, synovitis, subchondral bone changes, and osteophyte formation. Currently there is no treatment for OA except temporary pain relief and end-stage joint replacement surgery. We performed a pilot study to determine the effect of kartogenin (KGN, a small molecule) on both cartilage and subchondral bone in a rat model of OA using multimodal imaging techniques. OA was induced in rats (OA and KGN treatment group) by anterior cruciate ligament transection (ACLT) surgery in the right knee joint. Sham surgery was performed on the right knee joint of control group rats. KGN group rats received weekly intra-articular injection of 125 μM KGN 1 week after surgery until week 12. All rats underwent in vivo magnetic resonance imaging (MRI) at 3, 6, and 12 weeks after surgery. Quantitative MR relaxation measures (T1ρ and T2) were determined to evaluate changes in articular cartilage. Cartilage and bone turnover markers (COMP and CTX-I) were determined at baseline, 3, 6, and 12 weeks. Animals were sacrificed at week 12 and the knee joints were removed for micro-computed tomography (micro-CT) and histology. KGN treatment significantly lowered the T1ρ and T2 relaxation times indicating decreased cartilage degradation. KGN treatment significantly decreased COMP and CTX-I levels indicating decreased cartilage and bone turnover rate. KGN treatment also prevented subchondral bone changes in the ACLT rat model of OA. Thus, kartogenin is a potential drug to prevent joint deterioration in post-traumatic OA.",
keywords = "7T MRI, cartilage, kartogenin, Osteoarthritis, subchondral bone",
author = "Geetha Mohan and Sergey Magnitsky and Gerd Melkus and Karupppasamy Subburaj and Galateia Kazakia and Burghardt, {Andrew J.} and Alexis Dang and Lane, {Nancy E} and Sharmila Majumdar",
year = "2016",
month = "10",
day = "1",
doi = "10.1002/jor.23197",
language = "English (US)",
volume = "34",
pages = "1780--1789",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis

T2 - A pilot study

AU - Mohan, Geetha

AU - Magnitsky, Sergey

AU - Melkus, Gerd

AU - Subburaj, Karupppasamy

AU - Kazakia, Galateia

AU - Burghardt, Andrew J.

AU - Dang, Alexis

AU - Lane, Nancy E

AU - Majumdar, Sharmila

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Osteoarthritis (OA) is a major degenerative joint disease characterized by progressive loss of articular cartilage, synovitis, subchondral bone changes, and osteophyte formation. Currently there is no treatment for OA except temporary pain relief and end-stage joint replacement surgery. We performed a pilot study to determine the effect of kartogenin (KGN, a small molecule) on both cartilage and subchondral bone in a rat model of OA using multimodal imaging techniques. OA was induced in rats (OA and KGN treatment group) by anterior cruciate ligament transection (ACLT) surgery in the right knee joint. Sham surgery was performed on the right knee joint of control group rats. KGN group rats received weekly intra-articular injection of 125 μM KGN 1 week after surgery until week 12. All rats underwent in vivo magnetic resonance imaging (MRI) at 3, 6, and 12 weeks after surgery. Quantitative MR relaxation measures (T1ρ and T2) were determined to evaluate changes in articular cartilage. Cartilage and bone turnover markers (COMP and CTX-I) were determined at baseline, 3, 6, and 12 weeks. Animals were sacrificed at week 12 and the knee joints were removed for micro-computed tomography (micro-CT) and histology. KGN treatment significantly lowered the T1ρ and T2 relaxation times indicating decreased cartilage degradation. KGN treatment significantly decreased COMP and CTX-I levels indicating decreased cartilage and bone turnover rate. KGN treatment also prevented subchondral bone changes in the ACLT rat model of OA. Thus, kartogenin is a potential drug to prevent joint deterioration in post-traumatic OA.

AB - Osteoarthritis (OA) is a major degenerative joint disease characterized by progressive loss of articular cartilage, synovitis, subchondral bone changes, and osteophyte formation. Currently there is no treatment for OA except temporary pain relief and end-stage joint replacement surgery. We performed a pilot study to determine the effect of kartogenin (KGN, a small molecule) on both cartilage and subchondral bone in a rat model of OA using multimodal imaging techniques. OA was induced in rats (OA and KGN treatment group) by anterior cruciate ligament transection (ACLT) surgery in the right knee joint. Sham surgery was performed on the right knee joint of control group rats. KGN group rats received weekly intra-articular injection of 125 μM KGN 1 week after surgery until week 12. All rats underwent in vivo magnetic resonance imaging (MRI) at 3, 6, and 12 weeks after surgery. Quantitative MR relaxation measures (T1ρ and T2) were determined to evaluate changes in articular cartilage. Cartilage and bone turnover markers (COMP and CTX-I) were determined at baseline, 3, 6, and 12 weeks. Animals were sacrificed at week 12 and the knee joints were removed for micro-computed tomography (micro-CT) and histology. KGN treatment significantly lowered the T1ρ and T2 relaxation times indicating decreased cartilage degradation. KGN treatment significantly decreased COMP and CTX-I levels indicating decreased cartilage and bone turnover rate. KGN treatment also prevented subchondral bone changes in the ACLT rat model of OA. Thus, kartogenin is a potential drug to prevent joint deterioration in post-traumatic OA.

KW - 7T MRI

KW - cartilage

KW - kartogenin

KW - Osteoarthritis

KW - subchondral bone

UR - http://www.scopus.com/inward/record.url?scp=84991106451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991106451&partnerID=8YFLogxK

U2 - 10.1002/jor.23197

DO - 10.1002/jor.23197

M3 - Article

VL - 34

SP - 1780

EP - 1789

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 10

ER -